Reading Published Dose Ranges Correctly Retatrutides Phase 3 TRIUMPH-1 trial, with topline results reported by Eli Lilly in May 2026, evaluated three target doses 4mg, 9mg, and 12mg weekly with all arms starting at 2mg and escalating in steps every four weeks (2mg 4mg 6mg 9mg 12mg, depending on target arm) rather than starting at the target dose directly
The combination supports liver-fat use without producing the full glucose response of glucagon alone, and the signal persists between doses
But, always talk to a doctor before taking supplements, even if youre already on blood thinners
Key Terms Explained Meta-Analysis A statistical technique that combines results from multiple independent studies into a single analysis
Available as an oral capsule, injectable, or nasal spray, BPC-157 is highly versatile and often used alongside other therapies for enhanced effect
Here's what current research says about both options